TT,
It is a phase 1 / 2 trial, specifically targeting ASD / autism based on a number of Israeli studies that show the effectiveness of full spectrum cannabinoids (less than 0.3 % thc ) - the dolce strains should be more effective given higher levels of cbda , cbg, cbn , cbdb and p, - do you honestly think monash health with head of paediatric neurology would run a phase 1 and 2 trial without all dosage parameters in place -
From the NTI 5th May announcement:
"Commenting on the Study, A/Profressor Michael Fahey said:
It is exciting to undertake a properly planned and executed study on a novel CBD product.Many other studies do not have the rigor to ensure that the results are translatable to evidence based clinical treatments"
Your post is deliberately false and misleading, -- is it because of your apparent love /hate relationship with BL.
TT,It is a phase 1 / 2 trial, specifically targeting ASD /...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
-0.009(15.5%) |
Mkt cap ! $50.69M | |||
| Open | High | Low | Value | Volume |
| 5.4¢ | 5.4¢ | 4.8¢ | $180.7K | 3.515M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1625764 | 4.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.2¢ | 98041 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| NTI (ASX) Chart |